ecNumber*3.4.22.41#specificActivity*-999#specificActivityMaximum*#commentary*assay method#organism*Homo sapiens#literature*137265#!ecNumber*3.4.22.41#specificActivity*-999#specificActivityMaximum*#commentary*assay method#organism*Oryctolagus cuniculus#literature*137265#!ecNumber*3.4.22.41#specificActivity*-999#specificActivityMaximum*#commentary*adding E-64d (inhibitor) results in drastically inhibition of enzyme activity in cytosol and nucleus, fluorescence-labeled peptide substrate (benzyloxycarbonyl-Leu-Arg-4-methylcoumaryl-7-amide) with excitation wavelength 380 nm and emission wavelength 460 nm, confirmed by cathepsin F siRNA treatment; higher activity in nucleus than in cytosol, fluorescence-labeled peptide substrate (benzyloxycarbonyl-Leu-Arg-4-methylcoumaryl-7-amide) with excitation wavelength 380 nm and emission wavelength 460 nm, differentiation between cathepsin F and other cathepsins by using specific inhibitors and substrates#organism*Rattus norvegicus#literature*700092#